Thomas Grant v. HHS - Influenza, Guillain-Barre Syndrome (GBS) (2024)

Thomas Grant filed a petition under the National Vaccine Injury Compensation Program alleging that he suffered Guillain-Barre Syndrome (GBS) as a result of an influenza vaccine he received on October 3, 2018. The respondent conceded that Mr.

Grant is entitled to compensation, agreeing that his condition met the criteria set forth in the Vaccine Injury Table and that the case was timely filed, the vaccine was administered in the United States, and he met the statutory severity requirement. The court found Mr.

Grant entitled to compensation in 2021. Subsequent decisions addressed damages, with the Chief Special Master initially awarding $180,000.00 for pain and suffering and $9,475.75 for prior lost wages.

A damages hearing was held to resolve remaining components, leading to a supplemental ruling awarding additional lost wages and future lost wages. The parties ultimately stipulated to a final award.

The final decision awarded a lump sum of $240,210.84, which included compensation for pain and suffering, total lost earnings, and life care expenses for the first year. Additionally, an amount sufficient to purchase an annuity contract was awarded to cover future care items.

This award represents compensation for all elements of damages to which Mr. Grant is entitled.